newsfilter
← Latest News
GlobeNewswire·

Apogee Therapeutics Announces Agenda for Virtual R&D Day

SAN FRANCISCO and WALTHAM, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (NASDAQ:APGE), a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy